1. FALSE POSITIVE

    Bias May Taint Big-Pharma Research

    SAN ANSELMO, CA - NOVEMBER 23:  Antiretroviral pills Truvada sit on a tray at Jack's Pharmacy on November 23, 2010 in San Anselmo, California. A study published by the New England Journal of Medicine showed that men who took the daily antiretroviral pill Truvada significantly reduced their risk of contracting HIV.  (Photo Illustration by Justin Sullivan/Getty Images)

    Justin Sullivan / Getty Images

    Are researchers shilling for pharmaceutical companies in The New England Journal of Medicine? That’s the question raised by a Washington Post investigation that found that a disproportionate number of research articles in the leading journal were funded by drug companies and in many cases authored by a researcher who had accepted money from the company. And the journal is hardly the only offender. While the tangle of money and science may not lead directly to unscientific behavior, one can hypothesize that it increases the likelihood for some health-care hanky-panky.

    Read it at The Washington Post